Exodus Point Capital Management, LP Passage Bio, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $70,742 - $172,601	-26,595 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$6.24 - $10.2 $11,313 - $18,492	-1,813 Reduced 6.38%	26,595 $169,000
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $276,409 - $440,892	28,408 New	28,408 $283,000
Q2 2021 Aug 16, 2021	SELL	$12.44 - $19.45 $173,612 - $271,444	-13,956 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.24 - $29.83 $226,645 - $416,307	13,956 New	13,956 $244,000

33M

20.3K

500

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $50.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.